# CVM GFI #159 (VICH GL36) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish a Microbiological ADI - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-159-vich-gl36-studies-to-evaluate-the-safety-of-residues-of-veterinary-drugs-in-human-food-general-approach-to-establish-a-microbiological-adi/cfd44eba-11ff-45b5-9630-d842b8cf08bc

> FDA guidance document: CVM GFI #159 (VICH GL36) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish a Microbiological ADI. Issue date: January 21, 2022. Get complete insights and analysis.

---

## Details

- Title: CVM GFI #159 (VICH GL36) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish a Microbiological ADI
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Veterinary Medicine
- Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
- Issue Date: 2022-01-21
- Last Changed: 2022-01-21
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2003-D-0433">FDA-2003-D-0433</a>

## Related Documents

- [CVM GFI #265 Use of Data from Foreign Investigational Studies to Support Effectiveness of New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-265-use-of-data-from-foreign-investigational-studies-to-support-effectiveness-of-new-animal-drugs/f6cb70ad-ba2c-4653-958c-74dd08a7f819)
- [CVM GFI #278 Human User Safety in New and Abbreviated New Animal Drug Applications](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-278-human-user-safety-in-new-and-abbreviated-new-animal-drug-applications/0a0c64dc-c687-44fe-b47c-72ab2723a713)
- [CVM GFI #268 Adaptive and Other Innovative Designs for Effectiveness Studies of New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-268-adaptive-and-other-innovative-designs-for-effectiveness-studies-of-new-animal-drugs/aec0e84d-2ef0-4428-b0c0-3cb5a94073b5)